{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:44:38Z","timestamp":1777527878915,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.amjcard.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T23:09:12Z","timestamp":1557356952000},"page":"367-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Efficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus"],"prefix":"10.1016","volume":"124","author":[{"given":"Adam M.","family":"Fleddermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Magalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Main","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.05.009_bib0001","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamacardio.2018.1086","article-title":"Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment","volume":"3","author":"McCarthy","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0002","first-page":"362","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0003","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MJT.0000000000000937","article-title":"Use of direct oral anticoagulants in the treatment of left ventricular thrombus: systematic review of current literature","volume":"0","author":"Kajy","year":"2019","journal-title":"Am J Ther"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0005","first-page":"276","article-title":"Apixaban in left ventricular thrombi treatment \u2013 a report of seven cases","volume":"44","author":"Elikowski","year":"2018","journal-title":"Pol Merkur Lekarski"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0006","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11239-017-1560-7","article-title":"Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series","volume":"44","author":"Smetana","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0007","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ccr3.1917","article-title":"Use of direct oral anticoagulants in the treatment of left ventricular thrombi: a tertiary center experience and review of the literature","volume":"7","author":"Shokr","year":"2019","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0008","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/eurheartj\/ehx551","article-title":"Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first myocardial infarction","volume":"39","author":"Maniwa","year":"2018","journal-title":"European Heart J"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0009","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta\u2010analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0010","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0011","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0012","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.05.009_bib0013","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.amjcard.2018.09.026","article-title":"Efficacy of direct acting oral anticoagulant drugs in the treatment of left atrial appendage thrombus in patients with atrial fibrillation","volume":"123","author":"Fleddermann","year":"2019","journal-title":"Am J Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919305181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919305181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T04:41:54Z","timestamp":1562647314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919305181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0002914919305181"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.05.009","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}